DISCLOSURE:
When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission at no extra cost to you. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network, Amazon and Alibris.
Current Medicine 2005 4th 2005 ed. Trade paperback Fine Books In Good Condition. May Have a Small Publisher Mark. Ship Via Fedex. Shipping Time 7 To 10 Days. Bookseller With Over 20 Years In Book Trade.
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: Current Medicine Group] Softcover pp. 384 4th Edition [New York, NY, U.S.A.] [Publication Year: 2005]
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: Current Medicine Group] Softcover New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. [Irving, TX, U.S.A.] [Publication Year: 2005]
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: Current Medicine Group] Softcover New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. [Irving, TX, U.S.A.] [Publication Year: 2005]
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: SP SPRINGER] Softcover New. Ship within 24hrs. Satisfaction 100% guaranteed. I Ships from multiple Locations I "Special Note" We do not Provide Service On APO & PO BOX Box addresses. Delivery with In 7-14 working Day Only. This Books ship from the United Kingdom & USA other locations in India depending on your location and availability. [London, LONDO, United Kingdom] [Publication Year: 2005]
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: Springer, Berlin, Current Medicine Group] Softcover Druck auf Anfrage Neuware - Printed after ordering - This fourth edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials. The book is for practicing physicians, physician's assistants, pharmacists, nurse practitioners, nurses, and residents. [Einbeck, Germany] [Publication Year: 2005]
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: Current Medicine Group] Softcover New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. [Irving, TX, U.S.A.] [Publication Year: 2005]
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: Springer, Berlin, Current Medicine Group] Softcover Druck auf Anfrage Neuware - Printed after ordering - This fourth edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format. The book is organized into chapters by drug class, and details the pharmacologic characteristics of specific treatment entities. The clinical efficacy and limitations of the various drug therapies are discussed using supportive reference material from the most authoritative sources and published clinical trials. The book is for practicing physicians, physician's assistants, pharmacists, nurse practitioners, nurses, and residents. [Einbeck, Germany] [Publication Year: 2005]
ISBN10: 1573402214, ISBN13: 9781573402217, [publisher: Current Medicine Group] Softcover New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. [Irving, TX, U.S.A.] [Publication Year: 2005]
SR-ECOMMERCE. New. SR-ECOMMERCE ISBN 1573402214 9781573402217 [IN]
DISCLOSURE:
When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission at no extra cost to you. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network, Amazon and Alibris.
